Article thumbnail

Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina

By Claudia Sola, Ricardo O Lamberghini, Marcos Ciarlantini, Ana L Egea, Patricia Gonzalez, Elda G Diaz, Vanina Huerta, Jose Gonzalez, Alejandra Corso, Mario Vilaro, Juan P Petiti, Alicia Torres, Ana Vindel and Jose L Bocco
Topics: Case Report
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3111347
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). AI: Activation of PKC epsilon induces lactotroph proliferation through ERK1/ 2 in response to phorbol ester. Mol Cell Endocrinol
  2. (2011). Chambers HF: Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis
  3. (2010). Chambers HF: Community-associated meticillin-resistant Staphylococcus aureus. Lancet
  4. (2007). Chambers HF: Intermediate vancomycin susceptibility in a communityassociated MRSA clone. Emerg Infect Dis
  5. (2010). Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
  6. (2008). Community-associated methicillin-resistant Staphylococcus aureus, eastern Argentina. Diagn Microbiol Infect
  7. (2010). Daum RS: Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev
  8. (2008). Deshmukh H: First reported case of infective endocarditis caused by community-acquired methicillin-resistant Staphylococcus aureus not associated with healthcare contact in Brazil. Braz J Infect Dis
  9. (2010). Invasive infection caused by a community-associated methicillin-resistant Staphylococcus aureus strain not carrying Panton-Valentine leukocidin in South Korea.
  10. (2008). JE: Community-associated MRSA (CAMRSA): an emerging pathogen in infective endocarditis.
  11. (2008). Khan FN: Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus. Diagn Microbiol Infect Dis
  12. (2009). Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing. nineteenth informational supplement. CLSI,
  13. (2010). Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients.
  14. (2010). ML: Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev
  15. (2006). MRSA Collaborative Study Group: Evolution and molecular characterization of methicillinresistant Staphylococcus aureus epidemic and sporadic clones in Cordoba,
  16. (2010). O’Brien FG: Differentiation of clonal complex 59 community-associated methicillin-resistant Staphylococcus aureus in Western Australia. Antimicrob Agents Chemother
  17. (2009). Rahav G: Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis
  18. (2010). Razonable RR: Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis
  19. (2006). S aureus Endocarditis and Bacteremia Study Group: Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
  20. (2010). S: Community associated methicillin resistant Staphylococcus aureus (CA-MRSA) infective endocarditis in Italy.
  21. (1992). Saravolatz LD: Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med
  22. (2009). Staphylococcus aureus bloodstream infections: definitions and treatment. Clin Infect Dis
  23. (2009). Stobberingh EE: The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. Curr Mol Med
  24. (1997). Tenover FC: Methicillinresistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.
  25. (2009). YK: A case of primary infective endocarditis caused by community-associated methicillin-resistant Staphylococcus aureus in a healthy individual and colonization in the family. Yonsei Med J